Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Supply, Demand and Key Producers, 2024-2030
The global Neuromyelitis Optica Spectrum Disorders (NMOSD) market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Neuromyelitis optica (NMO), also known as Devic's disease, is a rare condition where the immune system damages the spinal cord and the nerves of the eyes (optic nerves).NMO can affect anyone at any age, but it's more common in women than men.
This report studies the global Neuromyelitis Optica Spectrum Disorders (NMOSD) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neuromyelitis Optica Spectrum Disorders (NMOSD), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neuromyelitis Optica Spectrum Disorders (NMOSD) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neuromyelitis Optica Spectrum Disorders (NMOSD) total market, 2019-2030, (USD Million)
Global Neuromyelitis Optica Spectrum Disorders (NMOSD) total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) total market, key domestic companies and share, (USD Million)
Global Neuromyelitis Optica Spectrum Disorders (NMOSD) revenue by player and market share 2019-2024, (USD Million)
Global Neuromyelitis Optica Spectrum Disorders (NMOSD) total market by Type, CAGR, 2019-2030, (USD Million)
Global Neuromyelitis Optica Spectrum Disorders (NMOSD) total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Neuromyelitis Optica Spectrum Disorders (NMOSD) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Pfizer, Fresenius, Teva, Sandoz, Intas, Nang Kuang Pharmaceutical, Tianjin King York and Baxter, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neuromyelitis Optica Spectrum Disorders (NMOSD) market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market, By Region:
1. How big is the global Neuromyelitis Optica Spectrum Disorders (NMOSD) market?
2. What is the demand of the global Neuromyelitis Optica Spectrum Disorders (NMOSD) market?
3. What is the year over year growth of the global Neuromyelitis Optica Spectrum Disorders (NMOSD) market?
4. What is the total value of the global Neuromyelitis Optica Spectrum Disorders (NMOSD) market?
5. Who are the major players in the global Neuromyelitis Optica Spectrum Disorders (NMOSD) market?
Neuromyelitis optica (NMO), also known as Devic's disease, is a rare condition where the immune system damages the spinal cord and the nerves of the eyes (optic nerves).NMO can affect anyone at any age, but it's more common in women than men.
This report studies the global Neuromyelitis Optica Spectrum Disorders (NMOSD) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neuromyelitis Optica Spectrum Disorders (NMOSD), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neuromyelitis Optica Spectrum Disorders (NMOSD) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neuromyelitis Optica Spectrum Disorders (NMOSD) total market, 2019-2030, (USD Million)
Global Neuromyelitis Optica Spectrum Disorders (NMOSD) total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) total market, key domestic companies and share, (USD Million)
Global Neuromyelitis Optica Spectrum Disorders (NMOSD) revenue by player and market share 2019-2024, (USD Million)
Global Neuromyelitis Optica Spectrum Disorders (NMOSD) total market by Type, CAGR, 2019-2030, (USD Million)
Global Neuromyelitis Optica Spectrum Disorders (NMOSD) total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Neuromyelitis Optica Spectrum Disorders (NMOSD) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Pfizer, Fresenius, Teva, Sandoz, Intas, Nang Kuang Pharmaceutical, Tianjin King York and Baxter, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neuromyelitis Optica Spectrum Disorders (NMOSD) market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Relapsing Form
- Monophasic Form
- Hospital
- Clinic
- Roche
- Pfizer
- Fresenius
- Teva
- Sandoz
- Intas
- Nang Kuang Pharmaceutical
- Tianjin King York
- Baxter
- CSL
- Grifols
- Octapharma
1. How big is the global Neuromyelitis Optica Spectrum Disorders (NMOSD) market?
2. What is the demand of the global Neuromyelitis Optica Spectrum Disorders (NMOSD) market?
3. What is the year over year growth of the global Neuromyelitis Optica Spectrum Disorders (NMOSD) market?
4. What is the total value of the global Neuromyelitis Optica Spectrum Disorders (NMOSD) market?
5. Who are the major players in the global Neuromyelitis Optica Spectrum Disorders (NMOSD) market?
1 SUPPLY SUMMARY
1.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Introduction
1.2 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Total Market by Region (by Headquarter Location)
1.3.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
1.3.3 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
1.3.4 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
1.3.5 Japan Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
1.3.6 South Korea Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
1.3.7 ASEAN Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
1.3.8 India Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Major Market Trends
2 DEMAND SUMMARY
2.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
2.2 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Region
2.2.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Region (2019-2024)
2.2.2 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Forecast by Region (2025-2030)
2.3 United States Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
2.4 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
2.5 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
2.6 Japan Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
2.7 South Korea Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
2.8 ASEAN Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
2.9 India Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
3 WORLD NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD) COMPANIES COMPETITIVE ANALYSIS
3.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Neuromyelitis Optica Spectrum Disorders (NMOSD) in 2023
3.2.3 Global Concentration Ratios (CR8) for Neuromyelitis Optica Spectrum Disorders (NMOSD) in 2023
3.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Company Evaluation Quadrant
3.4 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Overall Company Footprint Analysis
3.4.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Region Footprint
3.4.2 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Company Product Type Footprint
3.4.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Comparison
4.2.1 United States VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies and Market Share, 2019-2024
4.3.1 United States Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, (2019-2024)
4.4 China Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue and Market Share, 2019-2024
4.4.1 China Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, (2019-2024)
4.5 Rest of World Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Relapsing Form
5.2.2 Monophasic Form
5.3 Market Segment by Type
5.3.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024)
5.3.2 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2025-2030)
5.3.3 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024)
6.3.2 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2025-2030)
6.3.3 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.1.4 Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.2.4 Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Fresenius
7.3.1 Fresenius Details
7.3.2 Fresenius Major Business
7.3.3 Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.3.4 Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Fresenius Recent Developments/Updates
7.3.6 Fresenius Competitive Strengths & Weaknesses
7.4 Teva
7.4.1 Teva Details
7.4.2 Teva Major Business
7.4.3 Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.4.4 Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Teva Recent Developments/Updates
7.4.6 Teva Competitive Strengths & Weaknesses
7.5 Sandoz
7.5.1 Sandoz Details
7.5.2 Sandoz Major Business
7.5.3 Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.5.4 Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Sandoz Recent Developments/Updates
7.5.6 Sandoz Competitive Strengths & Weaknesses
7.6 Intas
7.6.1 Intas Details
7.6.2 Intas Major Business
7.6.3 Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.6.4 Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Intas Recent Developments/Updates
7.6.6 Intas Competitive Strengths & Weaknesses
7.7 Nang Kuang Pharmaceutical
7.7.1 Nang Kuang Pharmaceutical Details
7.7.2 Nang Kuang Pharmaceutical Major Business
7.7.3 Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.7.4 Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Nang Kuang Pharmaceutical Recent Developments/Updates
7.7.6 Nang Kuang Pharmaceutical Competitive Strengths & Weaknesses
7.8 Tianjin King York
7.8.1 Tianjin King York Details
7.8.2 Tianjin King York Major Business
7.8.3 Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.8.4 Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Tianjin King York Recent Developments/Updates
7.8.6 Tianjin King York Competitive Strengths & Weaknesses
7.9 Baxter
7.9.1 Baxter Details
7.9.2 Baxter Major Business
7.9.3 Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.9.4 Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Baxter Recent Developments/Updates
7.9.6 Baxter Competitive Strengths & Weaknesses
7.10 CSL
7.10.1 CSL Details
7.10.2 CSL Major Business
7.10.3 CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.10.4 CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 CSL Recent Developments/Updates
7.10.6 CSL Competitive Strengths & Weaknesses
7.11 Grifols
7.11.1 Grifols Details
7.11.2 Grifols Major Business
7.11.3 Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.11.4 Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Grifols Recent Developments/Updates
7.11.6 Grifols Competitive Strengths & Weaknesses
7.12 Octapharma
7.12.1 Octapharma Details
7.12.2 Octapharma Major Business
7.12.3 Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.12.4 Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Octapharma Recent Developments/Updates
7.12.6 Octapharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Industry Chain
8.2 Neuromyelitis Optica Spectrum Disorders (NMOSD) Upstream Analysis
8.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Midstream Analysis
8.4 Neuromyelitis Optica Spectrum Disorders (NMOSD) Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Introduction
1.2 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Total Market by Region (by Headquarter Location)
1.3.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
1.3.3 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
1.3.4 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
1.3.5 Japan Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
1.3.6 South Korea Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
1.3.7 ASEAN Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
1.3.8 India Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Major Market Trends
2 DEMAND SUMMARY
2.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
2.2 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Region
2.2.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Region (2019-2024)
2.2.2 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Forecast by Region (2025-2030)
2.3 United States Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
2.4 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
2.5 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
2.6 Japan Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
2.7 South Korea Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
2.8 ASEAN Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
2.9 India Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030)
3 WORLD NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD) COMPANIES COMPETITIVE ANALYSIS
3.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Neuromyelitis Optica Spectrum Disorders (NMOSD) in 2023
3.2.3 Global Concentration Ratios (CR8) for Neuromyelitis Optica Spectrum Disorders (NMOSD) in 2023
3.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Company Evaluation Quadrant
3.4 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Overall Company Footprint Analysis
3.4.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Region Footprint
3.4.2 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Company Product Type Footprint
3.4.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Comparison
4.2.1 United States VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies and Market Share, 2019-2024
4.3.1 United States Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, (2019-2024)
4.4 China Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue and Market Share, 2019-2024
4.4.1 China Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, (2019-2024)
4.5 Rest of World Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Relapsing Form
5.2.2 Monophasic Form
5.3 Market Segment by Type
5.3.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024)
5.3.2 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2025-2030)
5.3.3 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024)
6.3.2 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2025-2030)
6.3.3 World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.1.4 Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.2.4 Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Fresenius
7.3.1 Fresenius Details
7.3.2 Fresenius Major Business
7.3.3 Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.3.4 Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Fresenius Recent Developments/Updates
7.3.6 Fresenius Competitive Strengths & Weaknesses
7.4 Teva
7.4.1 Teva Details
7.4.2 Teva Major Business
7.4.3 Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.4.4 Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Teva Recent Developments/Updates
7.4.6 Teva Competitive Strengths & Weaknesses
7.5 Sandoz
7.5.1 Sandoz Details
7.5.2 Sandoz Major Business
7.5.3 Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.5.4 Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Sandoz Recent Developments/Updates
7.5.6 Sandoz Competitive Strengths & Weaknesses
7.6 Intas
7.6.1 Intas Details
7.6.2 Intas Major Business
7.6.3 Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.6.4 Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Intas Recent Developments/Updates
7.6.6 Intas Competitive Strengths & Weaknesses
7.7 Nang Kuang Pharmaceutical
7.7.1 Nang Kuang Pharmaceutical Details
7.7.2 Nang Kuang Pharmaceutical Major Business
7.7.3 Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.7.4 Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Nang Kuang Pharmaceutical Recent Developments/Updates
7.7.6 Nang Kuang Pharmaceutical Competitive Strengths & Weaknesses
7.8 Tianjin King York
7.8.1 Tianjin King York Details
7.8.2 Tianjin King York Major Business
7.8.3 Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.8.4 Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Tianjin King York Recent Developments/Updates
7.8.6 Tianjin King York Competitive Strengths & Weaknesses
7.9 Baxter
7.9.1 Baxter Details
7.9.2 Baxter Major Business
7.9.3 Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.9.4 Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Baxter Recent Developments/Updates
7.9.6 Baxter Competitive Strengths & Weaknesses
7.10 CSL
7.10.1 CSL Details
7.10.2 CSL Major Business
7.10.3 CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.10.4 CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 CSL Recent Developments/Updates
7.10.6 CSL Competitive Strengths & Weaknesses
7.11 Grifols
7.11.1 Grifols Details
7.11.2 Grifols Major Business
7.11.3 Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.11.4 Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Grifols Recent Developments/Updates
7.11.6 Grifols Competitive Strengths & Weaknesses
7.12 Octapharma
7.12.1 Octapharma Details
7.12.2 Octapharma Major Business
7.12.3 Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
7.12.4 Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Octapharma Recent Developments/Updates
7.12.6 Octapharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Industry Chain
8.2 Neuromyelitis Optica Spectrum Disorders (NMOSD) Upstream Analysis
8.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Midstream Analysis
8.4 Neuromyelitis Optica Spectrum Disorders (NMOSD) Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Neuromyelitis Optica Spectrum Disorders (NMOSD) Players in 2023
Table 12. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Company Evaluation Quadrant
Table 14. Head Office of Key Neuromyelitis Optica Spectrum Disorders (NMOSD) Player
Table 15. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Company Product Type Footprint
Table 16. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Company Product Application Footprint
Table 17. Neuromyelitis Optica Spectrum Disorders (NMOSD) Mergers & Acquisitions Activity
Table 18. United States VS China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share (2019-2024)
Table 23. China Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share (2019-2024)
Table 26. Rest of World Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share (2019-2024)
Table 29. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024) & (USD Million)
Table 31. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2025-2030) & (USD Million)
Table 32. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024) & (USD Million)
Table 34. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2025-2030) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 38. Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Pfizer Basic Information, Area Served and Competitors
Table 42. Pfizer Major Business
Table 43. Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 44. Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Pfizer Recent Developments/Updates
Table 46. Pfizer Competitive Strengths & Weaknesses
Table 47. Fresenius Basic Information, Area Served and Competitors
Table 48. Fresenius Major Business
Table 49. Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 50. Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Fresenius Recent Developments/Updates
Table 52. Fresenius Competitive Strengths & Weaknesses
Table 53. Teva Basic Information, Area Served and Competitors
Table 54. Teva Major Business
Table 55. Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 56. Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Teva Recent Developments/Updates
Table 58. Teva Competitive Strengths & Weaknesses
Table 59. Sandoz Basic Information, Area Served and Competitors
Table 60. Sandoz Major Business
Table 61. Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 62. Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Sandoz Recent Developments/Updates
Table 64. Sandoz Competitive Strengths & Weaknesses
Table 65. Intas Basic Information, Area Served and Competitors
Table 66. Intas Major Business
Table 67. Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 68. Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Intas Recent Developments/Updates
Table 70. Intas Competitive Strengths & Weaknesses
Table 71. Nang Kuang Pharmaceutical Basic Information, Area Served and Competitors
Table 72. Nang Kuang Pharmaceutical Major Business
Table 73. Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 74. Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Nang Kuang Pharmaceutical Recent Developments/Updates
Table 76. Nang Kuang Pharmaceutical Competitive Strengths & Weaknesses
Table 77. Tianjin King York Basic Information, Area Served and Competitors
Table 78. Tianjin King York Major Business
Table 79. Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 80. Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Tianjin King York Recent Developments/Updates
Table 82. Tianjin King York Competitive Strengths & Weaknesses
Table 83. Baxter Basic Information, Area Served and Competitors
Table 84. Baxter Major Business
Table 85. Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 86. Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Baxter Recent Developments/Updates
Table 88. Baxter Competitive Strengths & Weaknesses
Table 89. CSL Basic Information, Area Served and Competitors
Table 90. CSL Major Business
Table 91. CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 92. CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. CSL Recent Developments/Updates
Table 94. CSL Competitive Strengths & Weaknesses
Table 95. Grifols Basic Information, Area Served and Competitors
Table 96. Grifols Major Business
Table 97. Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 98. Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Grifols Recent Developments/Updates
Table 100. Octapharma Basic Information, Area Served and Competitors
Table 101. Octapharma Major Business
Table 102. Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 103. Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 104. Global Key Players of Neuromyelitis Optica Spectrum Disorders (NMOSD) Upstream (Raw Materials)
Table 105. Neuromyelitis Optica Spectrum Disorders (NMOSD) Typical Customers
LIST OF FIGURE
Figure 1. Neuromyelitis Optica Spectrum Disorders (NMOSD) Picture
Figure 2. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Total Market Size (2019-2030) & (USD Million)
Figure 4. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (2019-2030) & (USD Million)
Figure 13. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 16. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 18. China Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 23. India Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Neuromyelitis Optica Spectrum Disorders (NMOSD) by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Neuromyelitis Optica Spectrum Disorders (NMOSD) Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Neuromyelitis Optica Spectrum Disorders (NMOSD) Markets in 2023
Figure 27. United States VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type in 2023
Figure 31. Relapsing Form
Figure 32. Monophasic Form
Figure 33. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2019-2030)
Figure 34. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application in 2023
Figure 36. Hospital
Figure 37. Clinic
Figure 38. Neuromyelitis Optica Spectrum Disorders (NMOSD) Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
Table 1. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Neuromyelitis Optica Spectrum Disorders (NMOSD) Players in 2023
Table 12. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Company Evaluation Quadrant
Table 14. Head Office of Key Neuromyelitis Optica Spectrum Disorders (NMOSD) Player
Table 15. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Company Product Type Footprint
Table 16. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Company Product Application Footprint
Table 17. Neuromyelitis Optica Spectrum Disorders (NMOSD) Mergers & Acquisitions Activity
Table 18. United States VS China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share (2019-2024)
Table 23. China Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share (2019-2024)
Table 26. Rest of World Based Neuromyelitis Optica Spectrum Disorders (NMOSD) Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share (2019-2024)
Table 29. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024) & (USD Million)
Table 31. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2025-2030) & (USD Million)
Table 32. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024) & (USD Million)
Table 34. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2025-2030) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 38. Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Pfizer Basic Information, Area Served and Competitors
Table 42. Pfizer Major Business
Table 43. Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 44. Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Pfizer Recent Developments/Updates
Table 46. Pfizer Competitive Strengths & Weaknesses
Table 47. Fresenius Basic Information, Area Served and Competitors
Table 48. Fresenius Major Business
Table 49. Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 50. Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Fresenius Recent Developments/Updates
Table 52. Fresenius Competitive Strengths & Weaknesses
Table 53. Teva Basic Information, Area Served and Competitors
Table 54. Teva Major Business
Table 55. Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 56. Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Teva Recent Developments/Updates
Table 58. Teva Competitive Strengths & Weaknesses
Table 59. Sandoz Basic Information, Area Served and Competitors
Table 60. Sandoz Major Business
Table 61. Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 62. Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Sandoz Recent Developments/Updates
Table 64. Sandoz Competitive Strengths & Weaknesses
Table 65. Intas Basic Information, Area Served and Competitors
Table 66. Intas Major Business
Table 67. Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 68. Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Intas Recent Developments/Updates
Table 70. Intas Competitive Strengths & Weaknesses
Table 71. Nang Kuang Pharmaceutical Basic Information, Area Served and Competitors
Table 72. Nang Kuang Pharmaceutical Major Business
Table 73. Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 74. Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Nang Kuang Pharmaceutical Recent Developments/Updates
Table 76. Nang Kuang Pharmaceutical Competitive Strengths & Weaknesses
Table 77. Tianjin King York Basic Information, Area Served and Competitors
Table 78. Tianjin King York Major Business
Table 79. Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 80. Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Tianjin King York Recent Developments/Updates
Table 82. Tianjin King York Competitive Strengths & Weaknesses
Table 83. Baxter Basic Information, Area Served and Competitors
Table 84. Baxter Major Business
Table 85. Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 86. Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Baxter Recent Developments/Updates
Table 88. Baxter Competitive Strengths & Weaknesses
Table 89. CSL Basic Information, Area Served and Competitors
Table 90. CSL Major Business
Table 91. CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 92. CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. CSL Recent Developments/Updates
Table 94. CSL Competitive Strengths & Weaknesses
Table 95. Grifols Basic Information, Area Served and Competitors
Table 96. Grifols Major Business
Table 97. Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 98. Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Grifols Recent Developments/Updates
Table 100. Octapharma Basic Information, Area Served and Competitors
Table 101. Octapharma Major Business
Table 102. Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Product and Services
Table 103. Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 104. Global Key Players of Neuromyelitis Optica Spectrum Disorders (NMOSD) Upstream (Raw Materials)
Table 105. Neuromyelitis Optica Spectrum Disorders (NMOSD) Typical Customers
LIST OF FIGURE
Figure 1. Neuromyelitis Optica Spectrum Disorders (NMOSD) Picture
Figure 2. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Total Market Size (2019-2030) & (USD Million)
Figure 4. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (2019-2030) & (USD Million)
Figure 13. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 16. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 18. China Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 23. India Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Neuromyelitis Optica Spectrum Disorders (NMOSD) by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Neuromyelitis Optica Spectrum Disorders (NMOSD) Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Neuromyelitis Optica Spectrum Disorders (NMOSD) Markets in 2023
Figure 27. United States VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Neuromyelitis Optica Spectrum Disorders (NMOSD) Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type in 2023
Figure 31. Relapsing Form
Figure 32. Monophasic Form
Figure 33. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2019-2030)
Figure 34. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application in 2023
Figure 36. Hospital
Figure 37. Clinic
Figure 38. Neuromyelitis Optica Spectrum Disorders (NMOSD) Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
